Ian Gering

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 12

Top Topics

Cerebrospinal Fluid

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Tim Altendorf, Ian Gering, Beatrix Santiago-Schübel, Selma Aghabashlou Saisan, Gültekin Tamgüney, Markus Tusche, Dominik Honold, Sarah Schemmert, Wolfgang Hoyer, Jeannine Mohrlüder, Dieter Willbold
Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer's Disease and Other Tauopathies. International journal of molecular sciences 24 (3) (2023)
Mônika Aparecida Coronado, Ian Gering, Marc Sevenich, Danilo S Olivier, Mohammadamin Mastalipour, Marcos S Amaral, Dieter Willbold, Raphael Josef Eberle
The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses. Pharmaceutics 15 (3) (2023)
Tim Altendorf, Ian Gering, Beatrix Santiago-Schübel, Selma Aghabashlou Saisan, Gültekin Tamgüney, Markus Tusche, Dominik Honold, Sarah Schemmert, Wolfgang Hoyer, Jeannine Mohrlüder, Dieter Willbold
Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer's Disease and Other Tauopathies. International journal of molecular sciences 24 (3) (2023)
Mônika Aparecida Coronado, Ian Gering, Marc Sevenich, Danilo S Olivier, Mohammadamin Mastalipour, Marcos S Amaral, Dieter Willbold, Raphael Josef Eberle
The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses. Pharmaceutics 15 (3) (2023)
Mônika Aparecida Coronado, Ian Gering, Marc Sevenich, Danilo S Olivier, Mohammadamin Mastalipour, Marcos S Amaral, Dieter Willbold, Raphael Josef Eberle
The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses. Pharmaceutics 15 (3) (2023)
Tim Altendorf, Ian Gering, Beatrix Santiago-Schübel, Selma Aghabashlou Saisan, Gültekin Tamgüney, Markus Tusche, Dominik Honold, Sarah Schemmert, Wolfgang Hoyer, Jeannine Mohrlüder, Dieter Willbold
Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer's Disease and Other Tauopathies. International journal of molecular sciences 24 (3) (2023)
Raphael Josef Eberle, Mônika Aparecida Coronado, Ian Gering, Simon Sommerhage, Karolina Korostov, Anja Stefanski, Kai Stühler, Victoria Kraemer-Schulien, Lara Blömeke, Oliver Bannach, Dieter Willbold
Tau protein aggregation associated with SARS-CoV-2 main protease. PloS one 18 (8) (2023)
Raphael Josef Eberle, Ian Gering, Markus Tusche, Philipp N Ostermann, Lisa Müller, Ortwin Adams, Heiner Schaal, Danilo S Olivier, Marcos S Amaral, Raghuvir Krishnaswamy Arni, Dieter Willbold, Mônika Aparecida Coronado
Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Anne K Braczynski, Marc Sevenich, Ian Gering, Tatsiana Kupreichyk, Emil D Agerschou, Yannick Kronimus, Pardes Habib, Matthias Stoldt, Dieter Willbold, Jörg B Schulz, Jan-Philipp Bach, Björn H Falkenburger, Wolfgang Hoyer
Alpha-Synuclein-Specific Naturally Occurring Antibodies Inhibit Aggregation In Vitro and In Vivo. Biomolecules 12 (3) (2022)
Sarah Schemmert, Luana Cristina Camargo, Dominik Honold, Ian Gering, Janine Kutzsche, Antje Willuweit, Dieter Willbold
In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer's Disease. International journal of molecular sciences 22 (12) (2021)
Julia Post, Anja Schaffrath, Ian Gering, Sonja Hartwig, Birgit Knebel, Nadim Joni Shah, Karl-Josef Langen, Dieter Willbold, Janine Kutzsche, Antje Willuweit
Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1G93A Transgenic Mice. International journal of molecular sciences 22 (13) (2021)
Raphael Josef Eberle, Danilo S Olivier, Marcos S Amaral, Ian Gering, Dieter Willbold, Raghuvir Krishnaswamy Arni, Monika A Coronado
The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro. Viruses 13 (5) (2021)